Related Experiment Videos

China: government issues licences for three antiretrovirals

Richard Elliott

Canadian HIV/AIDS Policy & Law Review

|January 28, 2004

Abstract:

The Chinese government has approved the production and sale of at least three generic antiretroviral drugs used in treating people living with HIV/AIDS. The first applications were filed in late 2001 and approved in August and September 2002.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

High-throughput 3D phenotypic screening identifies repurposed MEK inhibitors as drivers of chondrogenesis for cartilage regeneration.

Frontiers in bioengineering and biotechnology·2026

The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models.

Nature communications·2025

Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion.

Nature communications·2025

Dyr726, a brain-penetrant inhibitor of PI3Kα, Type III receptor tyrosine kinases, and WNT signaling.

bioRxiv : the preprint server for biology·2025

High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma.

Gynecologic oncology·2024

Assessing options for poppers policy in Canada: A call to action for evidence-based policy reform.

The International journal on drug policy·2023

See all related articles